ExtremitiesFinancial

Extremity Reconstruction Market to Reach $6.5 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research

Increase in number of joint disorders such as osteoarthritis and atrophic arthritis and rise in awareness about advantages of small joint reconstruction devices drive the growth of the global extremity reconstruction market.

PORTLAND, Ore., May 18, 2022 /PRNewswire/ — Allied Market Research published a report, titled, Extremity Reconstruction Market by Product (Upper Extremity, Lower Extremity), by Material (Metallic Material, Ceramic Material, Polymeric Material, Natural Material): Global Opportunity Analysis and Industry Forecast, 2020-2030.” According to the report, the global extremity reconstruction industry generated $3.6 billion in 2020, and is expected to reach $6.5 billion by 2030, witnessing a CAGR of 6.3% from 2021 to 2030.

Drivers, Restraints, and Opportunities

Increase in number of joint disorders such as osteoarthritis and atrophic arthritis, surge in prevalence of diabetes and obesity that lead to joint disorders, and rise in awareness about advantages of small joint reconstruction devices drive the growth of the global extremity reconstruction market. However, unsupportive reimbursement scenarios, requirement for revision of surgeries after few years, and complications related to the extremity reconstruction surgery restrain the market growth. On the other hand, advancements in technology present new opportunities in the coming years.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/1716

Covid-19 Scenario

  • The number of extremity reconstruction surgeries reduced considerably during the pandemic as the hospital staff was shifted to take care of huge number of Covid-infected patients. These surgeries were carried out only in extreme cases.
  • The possibility of cross-contamination prevented many patients from undergoing the extremity reconstruction surgery during the pandemic. The number of surgeries is expected to rise post-pandemic.

Get detailed COVID-19 impact analysis on the Extremity Reconstruction Market- https://www.alliedmarketresearch.com/request-for-customization/1716?reqfor=covid

The upper extremity segment to maintain its lead position throughout the forecast period

Based on product, the upper extremity segment accounted for the largest market share in 2020, contributing to nearly 90% of the global extremity reconstruction market, and is expected to maintain its lead position throughout the forecast period. This is due to surge in cases of injuries across the globe. However, the lower extremity segment is estimated to witness the largest CAGR of 8.9% from 2021 to 2030, owing to increased awareness about the lower extremity reconstruction devices.

The metallic material segment to maintain its leadership status during the forecast period

Based on material, the metallic material segment held the highest market share in terms of revenue in 2020, accounting for nearly 87% of the global extremity reconstruction market, and is projected to maintain its leadership status during the forecast period. This is due to utilization in orthopedic surgeries for its various advantages. However, the natural material segment is projected to register the fastest CAGR of 13.6% from 2021 to 2030. This is attributed to increased demand for natural materials in orthopedic surgeries for its features such as biocompatibility, non-toxicity, and specific protein-binding sites.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/1716

North America generated the largest market share in 2020

Based on region, North America contributed to the highest market share in terms of revenue in 2020, accounting for nearly two-fifths of the global extremity reconstruction market. This is due to its advanced healthcare infrastructure and rise in chronic ailments especially in the U.S. However, Asia-Pacific is estimated to manifest the largest CAGR of 8.0% during the forecast period, owing to rise in geriatric population, rise in investments and R&D in the healthcare industry.

Leading Market Players

  • CONMED Corp.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Depuy Synthes
  • Integra LifeSciences Holdings Corporation
  • Wright Medical Group N.V.
  • Acumed, Inc.
  • Arthrex, Inc
  • Skeletal Dynamics LLC

Official Press Release- https://www.alliedmarketresearch.com/press-release/extremity-reconstruction-market.html

Similar Research Reports for Information, Communication and Technology:

Internet of Things in Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Medical Tourism Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

3D Cell Culture Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Neurovascular Devices Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Viral Vector and Plasmid DNA Manufacturing Market- Global Opportunity Analysis and Industry Forecast, 2021–2030

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com 
Web: https://www.alliedmarketresearch.com

SOURCE Allied Market Research

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button